{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:51:04Z","timestamp":1790049064633,"version":"4.0.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00188","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T04:33:32Z","timestamp":1518755612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India"],"prefix":"10.3389","volume":"9","author":[{"given":"Jahnavi","family":"Aluri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Mhatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouri","family":"Hule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Taur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramprasad","family":"Vedam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","article-title":"Major histocompatibility class II expression deficiency caused by RFXANK founder mutation: a survey of 35 patients","volume":"10","author":"Ouederni","year":"2011","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2017.04.006","article-title":"MHC class II deficiency: report of a novel mutation and special review","volume":"46","author":"Farrokhi","year":"2017","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","article-title":"MHC class I and II deficiencies","volume":"134","author":"Hanna","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0268-960X(96)90008-9","article-title":"Major histocompatibility complex class II deficiency: a clinical review","volume":"10","author":"Elhasid","year":"1996","journal-title":"Blood Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0092-8674(05)80090-X","article-title":"Complementation cloning of an MHC class I transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)","volume":"75","author":"Steimle","year":"1993","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/3081","article-title":"A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients","volume":"20","author":"Masternak","year":"1998","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1101\/gad.9.9.1021","article-title":"A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)","volume":"9","author":"Steimle","year":"1995","journal-title":"Genes Dev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10875-014-9993-7","article-title":"Rapid flow cytometric prenatal diagnosis of primary immunodeficiency [PID] disorders","volume":"34","author":"Mishra","year":"2014","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS clinical trials group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"Mutation taster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/emboj\/16.5.1045","article-title":"RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency","volume":"16","author":"Durand","year":"1997","journal-title":"EMBO J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmb.2010.08.025","article-title":"Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex","volume":"403","author":"Laird","year":"2010","journal-title":"J Mol Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1073\/pnas.94.12.6330","article-title":"Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5","volume":"94","author":"Scholl","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1074-7613(00)80016-3","article-title":"RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency","volume":"10","author":"Nagarajan","year":"1990","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1006\/mthe.2002.0804","article-title":"Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency","volume":"6","author":"Matheux","year":"2002","journal-title":"Mol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/adc.83.4.356","article-title":"Clinical course of patients with major histocompatibility complex class II deficiency","volume":"83","author":"Saleem","year":"2000","journal-title":"Arch Dis Child"},{"key":"B18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2141.2006.06213.x","article-title":"Human leucocyte antigen-identical hematopoietic stem cell transplantation in major histocompatibility complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections","volume":"134","author":"Renella","year":"2006","journal-title":"Br J Haematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1097\/MPH.0000000000000278","article-title":"Type II bare lymphocyte syndrome: role of peripheral blood flow cytometry and utility of stem cell transplant in treatment","volume":"37","author":"Kallen","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/MOP.0b013e32834cb9b0","article-title":"Neonatal screening for severe combined immunodeficiency","volume":"10","author":"Puck","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jaci.2012.10.040","article-title":"Thymic function in MHC class II-deficiency patients","volume":"131","author":"Lev","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaci.2013.04.024","article-title":"Newborn screening for SCID and T cell lymphopenia in California: results of the first two years","volume":"1","author":"Kwan","year":"2013","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T04:33:35Z","timestamp":1518755615000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2018.00188"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00188","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]},"article-number":"188"}}